ASRC Press Releases

NARB Panel Recommends Zero Technologies Discontinue Broadcast Ad Challenged by Clorox, Finds Advertiser Can Support Filter Claim made for ZeroWater Pitcher

A five-member panel of NARB has recommended that Zero Technologies, the maker of the ZeroWater Z-Pitcher, discontinue a broadcast advertisement that implies a competing product is not effective at filtering contaminants from drinking water.

Read More

NAD Finds Westport Can Support Claims for ZEPHREX-D Following Challenge by Acura Pharmaceuticals

NAD has determined that Westport Pharmaceuticals, LLC, maker of ZEPHREX-D nasal decongestant tablets, can support the claims challenged before NAD by Acura Pharmaceuticals, Inc., the maker of NEXAFED, a competing product.

Read More

NAD Determines Aggregated Online Reviews Don’t Support Claims that Euro-Pro’s Shark Vacuums Are ‘America’s Most Recommended,’ Euro-Pro to Appeal

NAD, in a case of first impression, determined that survey information culled from multiple online venues was insufficiently reliable and representative to support a broad “America’s Most Recommended” claim.

Read More

NAD Recommends iSatori Discontinue Certain Claims for ‘Energize’ Supplement, Finds Company Can Support Certain Claims

NAD has recommended that iSatori, Inc., discontinue certain claims for the company’s Energize dietary supplement, including claims of “8-Hour Efficacy Shown in Clinical Testing.” NAD determined, however, that the advertiser could support certain claims.

Read More

Accountability Program Catches Dropped Ball in LifeLock OBA Campaign: Requires All Players in Ad Ecosystem to Work as a Team to Ensure Compliance

The Online Interest-Based Advertising Accountability Program (Accountability Program) has determined that a communications failure among LifeLock, Inc., Initiative and AOL Advertising, Inc., allowed some personalized LifeLock ads to be served to consumers without the Digital Advertising Alliance’s Advertising Option Icon (AdChoices Icon).

Read More

NAD Recommends Hyperion Management Discontinue All Challenged Claims ‘Garcinia Cambogia Formula,’ Better Qualify Guarantee for ‘SaferColon’

NAD has recommended Hyperion Management, LLC, which markets the dietary supplements “Garcinia Cambogia Formula” and “SaferColon,” discontinue all challenged claims for the cambogia product and better disclose limitations the guarantee offered with “SaferColon.”

Read More